DIVISLAB have taken support and forming pole and flag . Going to break channel and start up move. Targets are mentioned, must comment if have any suggestion. NSE:DIVISLAB
Buying Moderna here, may be printing a double bottom on weekly. They arent going to let this pandemic go away so banking on more vaccines and more fun for a few more years at least. It is still WAY up from a few years ago so setting tight stops. Not advise.
CWBR closed 2 months ago a $15.0 Million Public Offering of Common Stock and Warrants at $0.72, so this is a safe upside in my opinion if you want to enter now. On the other hand, Cantor Fitzgerald brokerage has a $2.5 price target for it. 52 Week Range 0.34 - 2.27 Just bounced from its lowest support.
The stock has broken out and retested, therefore may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 2.5:1 SL is placed below support zone & the lower trendline. The target is placed near resistance.
ACRX has reached the lowest price @.46 a share, it has also double bottomed on the daily, the daily candle is bullish .. Looking to ride this buy for a long term. Going to ride it up to the red resistance trendline, if it becomes support it should reach $2 to $4. Happy New Year..
Analyst Vernon Bernardino from H.C. Wainwright, who reiterated a buy rating and $19 price target on ARDS, told investors Wednesday that Aridis Pharmaceuticals Inc 's monoclonal Covid-19 Antibody Cocktail is potentially First-in-Class treatment: "the cocktail binds to the S2 spike protein subunit, which mediates viral cell membrane fusion in SARS-CoV-2 variants...
Yesterday, JMP Securities Initiated Coverage on Quoin Pharmaceuticals, Ltd. (QNRX) with a Market Outperform rating and a price target of 8usd. Quoin Pharmaceuticals (NASDAQ: QNRX) is positioned to deliver the first FDA-approved treatment for Netherton Syndrome, a devastating disorder which affects 1 in every 200,000 people worldwide. This month, QNRX Signed...
Cipla weekly chart shows price is at a crucial point just standing on the 200DEMA line. Stock has been in the range of 873-1006, which currently is at the bottom of the range. Crucial to hold 200DEMA to move up, if breakdown then may move towards the lower range marked in the chart. *Only for educational purposes, not a buy/sell recommendation.
AbbVie - Short Term - We look to Buy at 119.00 (stop at 114.50) Previous resistance level of 119.95 broken. A move higher has resulted in prices breaking from the previous range and confirmed our bullish expectation. We have a Gap open at 118.86 from 03/12/2021 to 06/12/2021. Further upside is expected although we prefer to set longs at our bespoke support...
0.786 can be seen as a previous point of resistance now that price has moved higher than this level, it will be seen as a point of support for the breakdown of the rising wedge , a pattern that is commonly bearish (as you can see on the chart) Pharmaceutical companies are possibly hot right now, due to the emergence of the new COVID variant. Buy the Dip.
ACRX AcelRx Pharmaceuticals is a specialty pharmaceutical company that focuses on the development and commercialization of therapies for the treatment of acute pain. 52 Week Range 0.65 - 2.94 Sitting at all time low now. HC Wainwright has a 5usd price target for it. My take profits are: 1: $0.95 2: $1.23 Stop loss: $0.57
TMBR Timber Pharmaceuticals had a recent public offering price of $0.64 per share of common stock and accompanying common warrant. The warrants have an exercise price of $0.70 per share. The price is now 0.47usd There is a strong upside potential short term! Price Target 1: $0.85 Price Target 2: $1.37 Stop loss: $0.41 Looking forward to read your opinion about it.
Leep ur eyes on PHA. PHA/BTC tend to bounce from this level - Falling wedge - RSI divergence - 0.618 fib support if u have patience potential spike towards 0.00001632 sat+ Very risk coin manage your risk pls
Glenmark Pharmaceuticals is looking very bullish prior to its earnings. Daily RSI has formed a huge inverted H&S with a breakout. Down trendline broken Price has crossed above 20 and 40 SMA on the daily chart Three inside up candle pattern formation on the weekly chart
Will it break the triangle pattern formed from Dec 2019? Not easy to tell but I'm thinking of a bullish breakout. Time will tell.
ZNTL broke 80 again today and is displaying a strong monthly momentum chart. IBB regaining 160 hopefully will signal at least a moderate health care push that could push ZNTL into the 90s and beyond. Good luck traders!
On Thursday, the stock formed Gravestone doji with high volumes. But on the last day, the bears have been negated since fresh demand has come into place at the POC. Good price to enter, with stop loss as the red line.